Paroxysmal nocturnal haemoglobinuria: to prednisone or not to prednisone?--a case report of a patient previously treated with steroids for 15 yrs and significant response on eculizumab

European Journal of Haematology
Alexander RöthUlrich Dührsen

Abstract

Paroxysmal nocturnal haemoglobinuria (PNH) is a rare acquired haematopoietic stem cell disorder characterised by persistent haemolysis and platelet activation, severe end-organ damage, an increased risk of thrombosis and early mortality. We present the case of a 56-year-old male with long-standing PNH and significant disease-related morbidity who underwent steroid therapy for approximately 15 yrs before treatment with eculizumab, a humanized monoclonal antibody that blocks the terminal phase of the complement cascade at the C5 level. The patient presented with a severely impaired quality of life in 1997 and was diagnosed with PNH 8 months later, soon after which he was commenced on steroid therapy with prednisone. During long-term steroid therapy with progressive increases in prednisone dose, the patient had frequent haemolytic episodes as well as thrombosis and renal complications. He also experienced Cushing's syndrome with arterial hypertension, insulin-dependent diabetes mellitus, osteoporosis, acne and portal fibrosis. Eculizumab therapy was started in late-2009 and led to rapid improvements in haemoglobin and lactate dehydrogenase levels with a complete cessation of haemolytic episodes. Eculizumab has been well tolerated....Continue Reading

References

May 1, 1987·American Journal of Hematology·S IssaragrisilY Tang-naitrisorana
Nov 9, 1995·The New England Journal of Medicine·P HillmenJ V Dacie
Feb 6, 2004·The New England Journal of Medicine·Peter HillmenRussell P Rother
Jul 30, 2005·Blood·Charles ParkerUNKNOWN International PNH Interest Group
Sep 23, 2006·The New England Journal of Medicine·Peter HillmenLucio Luzzatto
Jan 16, 2009·Lancet·Charles Parker
Apr 18, 2009·Blood·Robert A Brodsky
Sep 3, 2011·European Journal of Haematology·Alexander Röth, Ulrich Dührsen
Mar 8, 2012·Current Opinion in Hematology·Charles J Parker
Apr 24, 2013·Blood·Anita HillPeter Hillmen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.